Shriners Hospitals for Children
Also known as: Kathy Prelack, PhD, RD | Louis-Nicolas Veilleux Ph.D. | Shriners Burns Hospital | Shriners Hospital for Children | Shriners Hospital for Children - Canada | Shriners Hospital for Children-Canadian Unit, Montreal, Quebec | Shriners Hospital for Children, Mayo Clinic | Shriners Hospitals for Children | Shriners Hospitals for Children-Boston | Shriners Hospitals for Children - Los Angeles | Shriners Hospitals for Children, Northern Calif. | Shriners Hospitals for Children-Portland | Shriners Hospital, St. Louis. MO
Highest phase reached
Phase 4
First clinical trial
Mar 1, 2000Last known activity
Apr 24, 2024
Timeline
1920s
- Jan 1, 1922
Shriners Hospitals for Children— Founded
Drugs by trial phase (35 distinct, 31 trials)
Phase 4 (13 own, 0 via acquisition)
Phase 3 (9 own, 0 via acquisition)
Phase 2 (6 own, 0 via acquisition)
Phase 1 (5 own, 0 via acquisition)
Indications
Studied for
- Bone Demineralization, Pathologic
- Burns
- Cerebral Palsy
- Congenital Abnormalities
- Constipation
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Diarrhea
- Hyperglycemia
- Hypophosphatasia
- Insulin Resistance
- Lower Extremity Deformities, Congenital
- Malnutrition
- Osteogenesis Imperfecta
- Paralysis
- Scoliosis
- Spinal Dysraphism
- Urinary Tract Infections
- Wounds and Injuries
Recent trials (50)
- NCT06284434OfficialPhase 3Apr 24, 2024
- NCT06284434CollaboratorPhase 3Apr 24, 2024
- NCT06284434Sponsor investigatorPhase 3Apr 24, 2024
- NCT06284434Lead sponsorPhase 3Apr 24, 2024
- NCT05730920Lead sponsorPhase 4Oct 19, 2022
- NCT05730920Sponsor investigatorPhase 4Oct 19, 2022
- NCT03537612Lead sponsorPhase 3Jun 22, 2018
- NCT03537612Sponsor investigatorPhase 3Jun 22, 2018
- NCT03064074CollaboratorPhase 1Apr 1, 2017
- NCT02452255CollaboratorPhase 2/Phase 3Nov 1, 2015
- NCT02462863CollaboratorPhase 1Oct 1, 2015
- NCT01598259Lead sponsorPhase 2May 1, 2014
- NCT01598259Reponsible party - principal investigatorPhase 2May 1, 2014
- NCT01957449CollaboratorPhase 2/Phase 3Dec 1, 2013
- NCT01773096Overall official - principal investigatorPhase 4May 1, 2013
Details
- Founded
- Tampa, FL, US Jan 1, 1922
- Last known activity
- Apr 24, 2024